AzTrials
AzTrials

Gingival PigmentationGMDAcidRCTNCT07708792

Influence of Adjunctive Acids Use on Esthetic Outcomes of Gingival Melanin Depigmentation: A Periodontal-Operative Pilot Randomized Clinical Trial

A study testing Citric acid in people with Gingival Pigmentation, run by Dijlah University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This pilot randomized clinical trial aims to evaluate the effect of adjunctive acid application on the esthetic outcomes of gingival melanin depigmentation. Participants with physiologic gingival hyperpigmentation will be randomly assigned to receive conventional gingival depigmentation with or without adjunctive acid… Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Gingival Pigmentation
What is being tested?
Citric acid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
Aug 2026to Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Adults aged 18-50 years.
  • Presence of physiologic gingival melanin pigmentation requiring treatment.
  • Good general health.
  • Good periodontal health or a healthy periodontium after initial periodontal therapy.
  • Willingness to participate and provide written informed consent.
  • Ability to attend all follow-up visits.

Who cannot join

  • Current smokers or tobacco users.
  • Pregnancy or breastfeeding.
  • History of systemic diseases that may affect wound healing (e.g., uncontrolled diabetes or immunocompromised conditions).
  • Use of medications known to affect gingival pigmentation or wound healing.
  • Previous gingival depigmentation treatment in the study area.
  • Active periodontal disease or oral infection. Known allergy or hypersensitivity to the study acid or related materials.

About this study

This pilot randomized clinical trial aims to evaluate the effect of adjunctive acid application on the esthetic outcomes of gingival melanin depigmentation. Participants with physiologic gingival hyperpigmentation will be randomly assigned to receive conventional gingival depigmentation with or without adjunctive acid application. The primary outcome is the improvement in gingival esthetics, while secondary outcomes include postoperative healing, pain, patient satisfaction, and recurrence of pigmentation. The findings of this study may help identify whether adjunctive acid application improves the clinical outcomes of gingival depigmentation procedures.

Being tested
Citric acid
Keywords
melanin, gingiva, depigmentation, pigmentation
Medical subject headings
Vitiligo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Citric acidDrug

    Adjunctive topical application of citric acid during gingival melanin depigmentation according to the study protocol to evaluate its effect on esthetic outcomes and healing.

Study groups in NCT07708792
Study groupRoleWhat they receive
Adjunctive Acid GroupExperimentalParticipants receive gingival melanin depigmentation using the standard surgical technique with adjunctive application of the study acid according to the study protocol.
Receives: Drug: Citric acid
Control GroupActive comparatorParticipants receive gingival melanin depigmentation using the standard surgical technique without adjunctive acid application.
Receives: Drug: Citric acid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Esthetic Outcome of Gingival Melanin Depigmentation

    Assessment of the esthetic improvement following gingival melanin depigmentation with or without adjunctive acid application using the study's predefined esthetic evaluation method.

    Measured: 3 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionOct 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07708792
Sponsor's protocol ID
83
Acronym
GMDAcidRCT
Status last verified
Jul 2026
First submitted
11 Jul 2026
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because informed consent for public data sharing was not obtained, and sharing could compromise participant confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing Citric acid in people with Gingival Pigmentation, run by Dijlah University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Esthetic Outcome of Gingival Melanin Depigmentation (time frame: 3 months after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in